NASDAQ · Medical - Devices
Spectral AI, Inc. (MDAI) Stock
$1.65
+0.61%
NASDAQ: MDAI
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
GlobeNewswire · Jul 8, 2026
DeepView® System Highlighted at the 2026 British Burn Association Annual Conference
GlobeNewswire · Jun 25, 2026
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
GlobeNewswire · Jun 12, 2026
Spectral AI to Participate in 2026 British Burn Association Annual Conference
GlobeNewswire · Jun 11, 2026
Spectral AI Announces Voting Results of Annual Meeting of Stockholders
GlobeNewswire · Jun 1, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Spectral AI, Inc.
Spectral AI, Inc. is led by CEO Vincent Stanley Capone, employs 78 people, headquartered in US, publicly traded since 2021.
Spectral AI, Inc. (MDAI) stock trades at $1.65 with a market capitalization of $52.51M. The stock is valued at a price-to-earnings (P/E) ratio of -4.70, price-to-book of -4.36, price-to-sales of 3.44. Over the past 52 weeks the stock has ranged between $1.18 and $2.97, and currently trades 44.4% below its 52-week high.
On profitability, Spectral AI, Inc. generates a return on equity (ROE) of 120.69% — well above the market average, a sign of a high-quality business, return on capital employed of 280.19%, an operating margin of -45.00%, a net profit margin of -69.27%.